Cargando…
COVID-19 among African Americans and Hispanics: Does gastrointestinal symptoms impact the outcome?
BACKGROUND: The coronavirus disease 2019 (COVID-19) disproportionately affected African Americans (AA) and Hispanics (HSP). AIM: To analyze the significant effectors of outcome in African American patient population and make special emphasis on gastrointestinal (GI) symptoms, laboratory values and c...
Autores principales: | Ashktorab, Hassan, Folake, Adeleye, Pizuorno, Antonio, Oskrochi, Gholamreza, Oppong-Twene, Philip, Tamanna, Nuri, Mehdipour Dalivand, Maryam, Umeh, Lisa N, Moon, Esther S, Kone, Abdoul Madjid, Banson, Abigail, Federman, Cassandra, Ramos, Edward, Awoyemi, Eyitope Ola, Wonni, Boubini Jones, Otto, Eric, Maskalo, Guttu, Velez, Alexandra Ogando, Rankine, Sheldon, Thrift, Camelita, Ekwunazu, Chiamaka, Scholes, Derek, Chirumamilla, Lakshmi Gayathri, Ibrahim, Mohd Elmugtaba, Mitchell, Brianna, Ross, Jillian, Curtis, Julencia, Kim, Rachel, Gilliard, Chandler, Mathew, Joseph, Laiyemo, Adeyinka, Kibreab, Angesum, Lee, Edward, Sherif, Zaki, Shokrani, Babak, Aduli, Farshad, Brim, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554449/ https://www.ncbi.nlm.nih.gov/pubmed/34754847 http://dx.doi.org/10.12998/wjcc.v9.i28.8374 |
Ejemplares similares
-
Correction: Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans
por: Ashktorab, Hassan, et al.
Publicado: (2022) -
Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans
por: Ashktorab, Hassan, et al.
Publicado: (2022) -
Fr101 COVID19 PATIENTS IN A TERTIARY HOSPITAL IN WASHINGTON DC: EFFECTS OF COMORBIDITIES AND GASTROINTESTINAL SYMPTOMS ON OUTCOME
por: Brim, Hassan, et al.
Publicado: (2021) -
Sa1000: DIARRHEA, ELEVATED AST, AND ELEVATION OF INFLAMMATORYRELATED BIOMARKERS IS A PREDICTOR FOR MORTALITY IN MINORITY HOSPITALISED COVID-19 PATIENTS
por: Ashktorab, Hassan, et al.
Publicado: (2022) -
Su1067: LIVER ENZYMES ALTERATION BUT NOT GI SYMPTOMS ARE ASSOCIATED WITH DEATH IN MINORITY COVID-19 PATIENTS WITH CANCER
por: Oskrochi, Gholamreza, et al.
Publicado: (2022)